Monash University fellowship aims to improve Gippsland clinical trial access
A new research project awarded to Dr Michelle Gooey will investigate barriers to clinical trial participation for residents living in regional Victoria.
FTMQ Health, written by our newsroom0 views
Dr Michelle Gooey has been awarded a Monash Partners Fellowship to lead a study designed to improve access to clinical trials for residents in Gippsland, the Latrobe Valley Express reported. The project is a partnership between Monash University and Latrobe Regional Health, where researchers will study how to make clinical trials programs more accessible for regional communities. [1]
According to the Latrobe Valley Express, the Victorian state government is sponsoring the fellowship under the Future Leader Fellows for Clinical Trials program. Dr Gooey was selected as one of six researchers through a competitive selection process. The study focuses on identifying specific barriers to participation and finding methods to make clinical research more inclusive for regional populations. [1]
Clinical trials are biomedical or behavioral research studies conducted on human participants to answer specific questions about interventions such as new treatments, safety, dosage, and efficacy. Research can only proceed after gaining approval from relevant health authorities and ethics committees to review the risk to benefit ratio for human subjects. [2]
As FTMQ Health reported earlier, clinical trials continue to explore diverse health interventions, including studies at Ohio State University evaluating whether daily probiotic supplements can reduce chemotherapy side effects for ovarian cancer patients. [5]
In short
- Dr Michelle Gooey received a Monash Partners Fellowship to study clinical trial accessibility in Gippsland.
- The fellowship is sponsored by the Victorian state government under the Future Leader Fellows for Clinical Trials program.
- Dr Gooey was one of six researchers selected through a competitive process.
- The project aims to identify participation barriers and improve inclusivity for regional communities.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Better accessibility to clinical trials in GippslandLatrobe Valley Express, 8d ago (the report this story comes from)
Background
- [2]Clinical trial on Wikipedia
- [3]Beetle on Wikipedia
- [4]Gippsland on Grokipedia
- [5]Ohio State trial examines whether probiotics reduce ovarian cancer treatment side effects FTMQ Health, 28d ago
Our newsroom writes these reports with the help of software, from the 5 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Trial begins on focused ultrasound for schizophrenia hallucinationsMedical Science, 15d ago
- Apple launches large study to evaluate health artificial intelligence appTop Stories, 5h ago
- NHS rolls out cancer blood test trial across 200 GP practicesHealth Care, 12d ago
- East Riding Council promotes free adult mental health serviceTop Stories, 37d ago
- Georgia aims to equip emergency rooms for rural maternal health careHealth Care, 27d ago
More in Top Stories
- United States updates federal health data privacy regulations for patient records5h ago
- Apple launches large study to evaluate health artificial intelligence app5h ago
- United States loses official measles elimination status following severe outbreak5h ago
- GLP1 weight loss drugs linked to nutrient shortages in exploratory study5h ago
- Large and small waist sizes linked to higher death risk5h ago
- UK government to end Palantir NHS England contract in 20291d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.